Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
THC and CBD for Chronic Pain
NCT03215940Phase 1Completed
- Sponsor
- University of Utah
- Start
- Feb 2018
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of dronabinol and cannabidiol in chronic pain, sponsored by University of Utah. Started Feb 2018; status: completed.
02
Drugs
dronabinolcannabidiol
03
Conditions
chronic pain
Beyond the preview
Go deeper on NCT03215940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03215940.